Larimar Therapeutics Files 8-K on Shareholder Votes
Ticker: LRMR · Form: 8-K · Filed: May 13, 2025 · CIK: 1374690
| Field | Detail |
|---|---|
| Company | Larimar Therapeutics, Inc. (LRMR) |
| Form Type | 8-K |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: LRMR
TL;DR
Larimar held a shareholder vote, details TBD.
AI Summary
Larimar Therapeutics, Inc. filed an 8-K on May 13, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain details about specific proposals or outcomes of any votes.
Why It Matters
This filing indicates that Larimar Therapeutics held a shareholder vote, which is a standard corporate governance event. The specific details of the vote are not disclosed in this particular filing.
Risk Assessment
Risk Level: low — This is a routine corporate filing regarding shareholder votes with no immediate financial or operational impact disclosed.
Key Players & Entities
- Larimar Therapeutics, Inc. (company) — Registrant
- ZAFGEN, INC. (company) — Former company name
- May 13, 2025 (date) — Date of report
FAQ
What specific matters were submitted to a vote of Larimar Therapeutics' security holders?
The filing states that matters were submitted to a vote of security holders, but it does not specify what those matters were.
When was the date of the shareholder meeting or vote?
The filing is dated May 13, 2025, and reports on matters submitted to a vote as of that date.
Did Larimar Therapeutics change its name recently?
The filing lists 'ZAFGEN, INC.' as a former company name, with name changes noted on March 1, 2010, and September 6, 2006.
What is Larimar Therapeutics' principal executive office address?
The principal executive offices are located at Three Bala Plaza East, Suite 506, Bala Cynwyd, Pennsylvania, 19004.
What is the IRS Employer Identification Number for Larimar Therapeutics?
The IRS Employer Identification Number for Larimar Therapeutics is 20-3857670.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding Larimar Therapeutics, Inc. (LRMR).